FDA lifts clin­i­cal hold on Rock­et's gene ther­a­py for heart fail­ure af­ter 3-month de­lay

4 years ago
Cell/Gene Tx
FDA+

Eli Lil­ly un­veils piv­otal da­ta from the star of its Der­mi­ra buy­out. But can it ri­val Dupix­ent in atopic der­mati­tis?

4 years ago
R&D

Covid-19 roundup: Tiny sam­ple size leads FDA to turn down Rigel's EUA; Seat­tle biotech to co-de­vel­op mR­NA vac­cine in ...

4 years ago
R&D
Coronavirus

Mer­ck joins its peers with plan to cut ac­cess to dis­count­ed drugs for con­tract phar­ma­cies

4 years ago
Pharma

Pros­e­cu­tors se­cure guilty plea in $110M biotech scam at Ver­mont ski re­sort

4 years ago
People

As US re­view of Eli Lil­ly-part­nered PD-1 gets un­der­way, In­novent touts an­oth­er front­line win in Chi­na

4 years ago
R&D
China

Pfiz­er, US Army nab a new ap­proval for a decades-old vac­cine

4 years ago
FDA+

Lat­est news on Fri­day af­ter­noon CRL; A big no to Aduhelm; Re­mem­ber­ing Tachi with Jim Wil­son and Bill Clin­ton; and ...

4 years ago
Weekly

FDA re­jects Sesen Bio's blad­der can­cer pitch, send­ing shares spi­ral­ing back to pen­ny stock ter­ri­to­ry

4 years ago
FDA+

Mer­ck takes home an FDA win for a Roger Perl­mut­ter fa­vorite, po­ten­tial­ly crack­ing open big mar­ket

4 years ago
R&D
FDA+

Covid-19 roundup: Io­n­is joins ranks of firms man­dat­ing Covid-19 vac­cine for staffers; Boost­ers are big mon­ey — ...

4 years ago
Coronavirus

Mus­tang inks a deal for in vi­vo CAR-T tech from the Mayo Clin­ic; How a spilled cup of tea land­ed one biotech $11.7 ...

4 years ago
News Briefing

Vi­for blasts FDA's 'reck­less' re­nam­ing of 4 drugs un­der the same mol­e­cule moniker

4 years ago
Pharma
FDA+

As Aubrey de Grey in­ves­ti­ga­tion swirled, SENS CEO left foun­da­tion in Ju­ly — re­port

4 years ago
People

New drug ap­pli­ca­tion fil­ings with FDA to cost more than $3M for first time ever in 2022

4 years ago
Pharma
FDA+

Robert Baze­more makes Hutchmed deal his grand fi­nale as Epizyme CEO; Black Di­a­mond reshuf­fles the deck with ...

4 years ago
Peer Review

Longeveron's cell ther­a­py flops ear­ly walk test study as ex­ecs tout flim­sy sup­port­ing da­ta

4 years ago
Cell/Gene Tx

Vec­tura board says it will unan­i­mous­ly back a Philip Mor­ris takeover

4 years ago
Deals

Jazz earns ex­pand­ed ap­proval for drug with con­tro­ver­sial his­to­ry, prompt­ing ex­pert push­back

4 years ago
FDA+

Ipsen with­draws NDA for rare bone dis­ease treat­ment less than 3 months af­ter win­ning pri­or­i­ty re­view

4 years ago
R&D
FDA+

Long-time FDA leader El­lis Unger ex­its as ex­o­dus of high-rank­ing of­fi­cials con­tin­ues

4 years ago
FDA+

FDA clears 3rd shot of mR­NA Covid-19 vac­cines for the im­muno­com­pro­mised

4 years ago
FDA+
Coronavirus

Eli Lil­ly joins the grow­ing ranks of Big Phar­ma play­ers man­dat­ing vac­ci­na­tions for most staffers

4 years ago
Pharma

No­vavax, Fu­ji­film plow ahead on Covid-19 vac­cine pro­duc­tion de­spite OWS set­back

4 years ago
Coronavirus
Manufacturing
First page Previous page 662663664665666667668 Next page Last page
A service from the Financial Times